Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (37)
Alessandro Villa & Michal Kuten-Shorrer. (2023) Pathogenesis of Oral Toxicities Associated with Targeted Therapy and Immunotherapy. International Journal of Molecular Sciences 24:9, pages 8188.
Crossref
Crossref
Navya Anna Paul, Ramesh Bhat M, Jyothi Jayaraman, Michelle Fernandes & Sukumar D. (2022) Lichenoid eruption: a hitherto unknown side effect of levetiracetam. Neurological Sciences 43:11, pages 6579-6581.
Crossref
Crossref
Yee Kiat Heng & Yen Loo Lim. 2022. Drug Eruptions. Drug Eruptions
153
164
.
Jhansi Arumugam, B Karthik Bommannan, Jayachandran Kalaiyarasi & Shirley Sundersingh. (2021) Isolated Central Nervous System Blast Crisis in Chronic Myeloid Leukemia - Report of Two Cases. Indian Journal of Medical and Paediatric Oncology 41:05, pages 781-783.
Crossref
Crossref
Sicília Rezende Oliveira, Luciana Gravito de Azevedo Branco, Amanda Leal Rocha, Denise Vieira Travassos, Gustavo Henrique Romani Magalhães, Felipe Paiva Fonseca, Ricardo Alves Mesquita, Lucas Guimarães Abreu & Tarcília Aparecida da Silva. (2019) Association of oral mucosa hyperpigmentation with imatinib mesylate use: a cross-sectional study and a systematic literature review. Clinical Oral Investigations 23:12, pages 4371-4382.
Crossref
Crossref
Leanne Teoh, Geraldine Moses & Michael J. McCullough. (2019) A review and guide to drug‐associated oral adverse effects—Oral mucosal and lichenoid reactions. Part 2. Journal of Oral Pathology & Medicine 48:7, pages 637-646.
Crossref
Crossref
Valeria Mateeva & Snejina Vassileva. 2019. Advances in Integrative Dermatology. Advances in Integrative Dermatology
163
185
.
Caroline Robert, Christina Mateus & Alexander M. M. Eggermont. 2018. Side Effects of Medical Cancer Therapy. Side Effects of Medical Cancer Therapy
285
313
.
Gian Paolo Bombeccari, Umberto Garagiola, Francesco Pallotti, Margherita Rossi, Massimo Porrini, Aldo Bruno Giannì & Francesco Spadari. (2017) Hyperpigmentation of the hard palate mucosa in a patient with chronic myeloid leukaemia taking imatinib. Maxillofacial Plastic and Reconstructive Surgery 39:1.
Crossref
Crossref
Emmanuelle Vigarios, Joel B. Epstein & Vincent Sibaud. (2017) Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors. Supportive Care in Cancer 25:5, pages 1713-1739.
Crossref
Crossref
Arthur Schmouchkovitch, Héloïse Herry, Philippe Thuillier, Véronique Kerlan, Camille Fleuret, Guy Le Toux & Sylvie Boisramé. (2017) Oral and vulvo-vaginal lichenoid reactions due to mitotane (Lysodren). Medicine 96:2, pages e5075.
Crossref
Crossref
Prakash Mani, Kothandaramasamy Rajagopalan, Geetharani Gopalan & Sathesh Pandian. (2016) THE PROSPECTIVE OBSERVATIONAL STUDY ON CUTANEOUS ADVERSE DRUG REACTIONS TO CHEMOTHERAPY. Journal of Evidence Based Medicine and Healthcare 3:59, pages 3212-3219.
Crossref
Crossref
Michael J. Payette, Gillian Weston, Stephen Humphrey, JiaDe Yu & Kristen E. Holland. (2015) Lichen planus and other lichenoid dermatoses: Kids are not just little people. Clinics in Dermatology 33:6, pages 631-643.
Crossref
Crossref
James B. Macdonald, Brooke Macdonald, Loren E. Golitz, Patricia LoRusso & Aleksandar Sekulic. (2015) Cutaneous adverse effects of targeted therapies. Journal of the American Academy of Dermatology 72:2, pages 203-218.
Crossref
Crossref
Anna Yuan & Sook-Bin Woo. (2015) Adverse drug events in the oral cavity. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 119:1, pages 35-47.
Crossref
Crossref
M. Pretel-Irazabal, A. Tuneu-Valls & N. Ormaechea-Pérez. (2014) Adverse Skin Effects of Imatinib, a Tyrosine Kinase Inhibitor. Actas Dermo-Sifiliográficas (English Edition) 105:7, pages 655-662.
Crossref
Crossref
M. Pretel-Irazabal, A. Tuneu-Valls & N. Ormaechea-Pérez. (2014) Efectos adversos cutáneos del imatinib (inhibidor de la tirosín cinasa). Actas Dermo-Sifiliográficas 105:7, pages 655-662.
Crossref
Crossref
A.-S. Dupond. (2014) Liquen plano y dermatosis liquenoides. EMC - Dermatología 48:3, pages 1-12.
Crossref
Crossref
V. Sibaud, F. Boralevi, E. Vigarios & J.-C. Fricain. (2014) Toxicité endobuccale des thérapies ciblées anticancéreuses. Annales de Dermatologie et de Vénéréologie 141:5, pages 354-363.
Crossref
Crossref
Raed O. Alhusayen, Sandra R. Knowles & Neil H. Shear. 2013. Dermatologic Principles and Practice in Oncology. Dermatologic Principles and Practice in Oncology
33
46
.
Caroline Robert, Vincent Sibaud & Christine Mateus. 2013. Dermatologic Principles and Practice in Oncology. Dermatologic Principles and Practice in Oncology
196
207
.
V. Brazzelli, V. Grasso & G. Borroni. (2013) Imatinib, dasatinib and nilotinib: a review of adverse cutaneous reactions with emphasis on our clinical experience. Journal of the European Academy of Dermatology and Venereology 27:12, pages 1471-1480.
Crossref
Crossref
Caroline Robert, Christina Mateus & Alexander M. M. Eggermont. 2013. Side Effects of Medical Cancer Therapy. Side Effects of Medical Cancer Therapy
381
419
.
Caroline Robert, Vincent Sibaud, Christine Mateus & Basil S. Cherpelis. (2012) Advances in the Management of Cutaneous Toxicities of Targeted Therapies. Seminars in Oncology 39:2, pages 227-240.
Crossref
Crossref
Valeria Brazzelli, Francesca Muzio, Giambattista Manna, Erica Moggio, Camilla Vassallo, Ester Orlandi, Giacomo Fiandrino, Marco Lucioni & Giovanni Borroni. (2012) Photoinduced dermatitis and oral lichenoid reaction in a chronic myeloid leukemia patient treated with imatinib mesylate. Photodermatology, Photoimmunology & Photomedicine 28:1, pages 2-5.
Crossref
Crossref
A.L. Watters, J.B. Epstein & M. Agulnik. (2011) Oral complications of targeted cancer therapies: A narrative literature review. Oral Oncology 47:6, pages 441-448.
Crossref
Crossref
U. Mattsson, S. Halbritter, E. Mörner Serikoff, L. Christerson & G. Warfvinge. (2011) Oral pigmentation in the hard palate associated with imatinib mesylate therapy: a report of three cases. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 111:5, pages e12-e16.
Crossref
Crossref
. 2011. Andrews' Diseases of the Skin. Andrews' Diseases of the Skin
88
137
.
S. M. Breathnach. 2010. Rook's Textbook of Dermatology. Rook's Textbook of Dermatology
1
177
.
S. M. Breathnach. 2010. Rook's Textbook of Dermatology. Rook's Textbook of Dermatology
1
28
.
Zuriñe Martínez de Lagrán, Ma Rosario González-Hermosa, Bruno Blaya-Álvarez & José Luis Díaz-Pérez. (2009) Un caso de liquen plano asociado a tratamiento con imatinib. Medicina Clínica 133:20, pages 805-806.
Crossref
Crossref
E. Sendagorta, P. Herranz, M. Feito, P. Ramírez, R. Feltes, U. Floristán, A. Mariño-Enriquez & M. Casado. (2009) Lichenoid drug eruption related to imatinib: report of a new case and review of the literature. Clinical and Experimental Dermatology 34:7, pages e315-e316.
Crossref
Crossref
Lorena Leal Canosa, María José Fuente González & Miquel Ribera Pibernat. (2009) Efectos secundarios cutáneos de los fármacos antineoplásicos (II): inhibidores de cinasas y anticuerpos monoclonales. Piel 24:8, pages 427-439.
Crossref
Crossref
F Femiano, A Lanza, C Buonaiuto, F Gombos, R Rullo, V Festa & N Cirillo. (2008) Oral manifestations of adverse drug reactions: guidelines. Journal of the European Academy of Dermatology and Venereology 22:6, pages 681-691.
Crossref
Crossref
Noushin Heidary, Haley Naik & Susan Burgin. (2008) Chemotherapeutic agents and the skin: An update. Journal of the American Academy of Dermatology 58:4, pages 545-570.
Crossref
Crossref
Ilhami Kiki, Mustafa Atasoy, Nesrin Gursan, Mehmet Gundogdu, Fuat Erdem & Sevki Ozdemir. (2007) LICHENOID DRUG ERUPTION ASSOCIATED WITH IMATINIB MESYLATE: TWO CASES. Electronic Journal of General Medicine 4:1, pages 50-53.
Crossref
Crossref
Robert P. NelsonJrJr, Kenneth Cornetta, Kelly E. Ward, Srinivasan Ramanuja, Chris Fausel & Larry D. Cripe. (2006) Desensitization to imatinib in patients with leukemia. Annals of Allergy, Asthma & Immunology 97:2, pages 216-222.
Crossref
Crossref